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Abstract
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian gene
regulation. In general, cytosine-phosphatidyl-guanosine (CpG)-methylated promoters are transcriptionally repressed and
nuclear proteins such as MECP2, MBD1, MBD2, and MBD4 bind CpG-methylated DNA and contribute to epigenetic silencing.
Methylation of viral DNA also regulates gene expression of Epstein-Barr virus (EBV), which is a model of herpes virus latency.
In latently infected human B cells, the viral DNA is CpG-methylated, the majority of viral genes is repressed and virus
synthesis is therefore abrogated. EBV’s BZLF1 encodes a transcription factor of the AP-1 family (Zta) and is the master gene
to overcome viral gene repression. In a genome-wide screen, we now identify and characterize those viral genes, which Zta
regulates. Among them are genes essential for EBV’s lytic phase, which paradoxically depend on strictly CpG-methylated
promoters for their Zta-induced expression. We identified novel DNA recognition motifs, termed meZRE (methyl-Zta-
responsive element), which Zta selectively binds in order to ‘read’ DNA in a methylation- and sequence-dependent manner
unlike any other known protein. Zta is a homodimer but its binding characteristics to meZREs suggest a sequential, non-
palindromic and bipartite DNA recognition element, which confers superior DNA binding compared to CpG-free ZREs. Our
findings indicate that Zta has evolved to transactivate cytosine-methylated, hence repressed, silent promoters as a rule to
overcome epigenetic silencing.
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Introduction
The methylation of cytosines in CpG dinucleotides in
mammalian DNA has long been associated with the regulation
of transcription of that DNA. The details of this regulation,
however, are only now being uncovered. For example genes first
expressed in murine primordial germ cells after migration to the
urogenital ridge are repressed prior to their migration by
methylation of CpGs; the loss of methylation at their promoters
correlates with these genes being transcribed [1]. An example in
which expressed genes are repressed during differentiation is
provided by murine embryonic stem cells induced to differentiate
into neurons [2]. In this example, 2.3% of analyzed promoters
become hypermethylated following differentiation with the
associated genes being transcriptionally repressed leading to a loss
of pluripotency. These examples demonstrate that CpG methyl-
ation is strictly linked to epigenetic gene silencing but are difficult
to dissect mechanistically in part because of the complexity of the
cues for differentiation that underlie them.
We have examined the fundamental events in the life-cycle of
the human tumor virus, Epstein-Barr virus (EBV), in which it first
establishes its infection in B-lymphocytes, drives them to
proliferate, and then evolves to support its own productive
infection in these cells. These experiments have allowed a
dissection of the role of methylation of CpG dinucleotides in
repressing and activating transcription of genes required for EBV’s
life cycle. Our initial experiments demonstrated that EBV uses the
gradual methylation of its genome both to ensure its initial
infection does not produce viral progeny to kill its host and later to
activate transcription of genes necessary such that it can produce
viral progeny [3].
EBV-infected cells can express two sets of viral genes that
relate either to the latent or lytic phases of EBV’s life cycle [4].
In newly infected B cells, EBV establishes a strictly latent
infection. In these cells few viral genes termed latent genes are
expressed, which are instrumental for the induction and
maintenance of cellular proliferation and viral latency; some
of which are also causally associated with EBV’s being a human
tumor virus [5]. Latently infected B cells can give rise to
progeny virus, a process which requires the induction of a set of
viral genes distinct from the set of EBV’s latent genes. During de
novo virus synthesis, about 80 lytic genes of EBV are expressed
that asynchronously support viral DNA amplification and
encode viral structural components to allow virus morphogen-
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esis and release of progeny virus. The transition from viral
latency to productive, lytic infection is orchestrated by two viral
genes, BZLF1 and BRLF1, which encode the transcription
factors, Zta (also called Z, ZEBRA, or EB1) and Rta (also called
R), respectively. The former is a master regulator of EBV’s
switch needed to induce the lytic phase of its life cycle in latently
infected B cells [6,7].
Zta is a basic leucine zipper (bZIP) transcription factor, which is
modular in structure with a dedicated transactivation domain and
a basic region that mediates DNA contact adjacent to a coiled-coil
dimerization domain (for a review see [8]). Three important
features of Zta include its ability to (i) bind sequence-specifically to
Zta-response elements (ZREs) [9], (ii) transactivate viral genes
[10], and (iii) serve as a replication factor activating the lytic origin
of viral DNA replication [11]. Zta and Rta have non-redundant
functions but cooperate to disrupt virus latency and control the
regulated expression of all lytic viral genes [12].
The control of expression of viral genes needed to establish EBV’s
latency and eventually to allow its escape from latency has been
unclear. A global screen revealed that the viral DNA is unmethylated
in virions and acquires methylated CpG dinucleotides in latently
EBV-infected B cells slowly over time [3]. Surprisingly, the functions
of BZLF1 and the methylation at CpGs are intimately connected.
Previous papers suggested that Zta can bind to DNA even if it is
CpG-methylated [13–15]. Our experimental data indicated that
CpG methylation of genomic EBV DNA is an essential prerequisite
for EBV’s lytic phase including the synthesis of progeny virus [3].
CpG methylation of the promoter of the BRLF1 gene was proposed
to be critical for Zta regulating it [13,15] but a detailed genetic
analysis of the BRLF1 promoter did not support this proposition [3].
Therefore we set out to identify viral genes, which both are regulated
by Zta and are dependent for expression on the state of CpG
methylation of genomic EBV DNA.
In genome-wide screens with unmethylated and methylated
recombinant EBV DNA we now report that Zta can bind to many
sites if they include methylated CpGs. These screen include
Author Summary
Epstein-Barr virus (EBV) is a model of human tumor viruses
and viral latency. We have found previously that (i) EBV
DNA is unmethylated upon infection, but becomes
methylated over time by the host B cell, and (ii) the
BZLF1-encoded protein, Zta (a cousin to AP-1), induces the
viral lytic cycle, but it prefers binding sites that are CpG-
methylated. As a consequence, the lytic phase gets
delayed until enough methylation of viral DNA has
occurred. The molecular basis of this mechanism has not
been addressed but in a genome-wide screen, we now
identify and characterize those viral genes, which Zta
regulates. Among them are genes essential for EBV’s lytic
phase, which paradoxically depend on strictly CpG-
methylated promoters for their Zta-induced expression.
Our findings indicate that Zta has evolved to transactivate
cytosine-methylated, hence repressed, silent promoters as
a rule to overcome epigenetic silencing. In this way, the
EBV virus has created its own time-dependent, epigenetic
switch to control its biphasic life cycle.
Figure 1. Zta binds preferentially to CpG-methylated EBV DNA in vitro. In vitro immunoprecipitation assays with GFP:BZLF1 and subsequent
deep sequencing analysis indicate the preferred binding of Zta to CpG-methylated EBV DNA. E.coli-derived genomic EBV DNA free of methylated CpG
dinucleotides (blue) and after complete in vitro CpG methylation by the methyltransferase M.SssI (red) was used as probes for the GFP:BZLF1
immunoprecipitations. Reads were mapped to the reference B95.8 EBV genome. Depicted is the read depth at single base pair resolution. In addition,
the difference of read depth between the two experiments (Ddepth, black) is calculated and shown at the bottom.
doi:10.1371/journal.ppat.1001114.g001
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Figure 2. Identification of methylation-dependent Zta binding to selected viral promoter elements in vivo and in vitro. Deep
sequencing data obtained from in vitro immunoprecipitation experiments with GFP:BZLF1 as in Figure 1 are plotted on selected genes and their
promoters as indicated. EBV DNA free of CpG-methylation (blue) and after full methylation by the methyltransferase M.SssI (red) were used as probes
CpG-Dependent Transcriptional Activation
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chromatin-immunoprecipitations coupled to deep sequencing
(ChIP-seq), which have identified highly selective binding of Zta
to certain CpG-methylated promoters of lytic viral genes, some of
which are essential for the completion of EBV’s lytic phase.
Detailed biomathematical, functional and biochemical analyses
have revealed a novel CG dinucleotide-containing motif, termed
meZRE, to which Zta binds exclusively and with superior affinity
if it includes methylated cytosines. Our experiments suggest that
transcription factors can directly activate epigenetically silenced
genes in a sequence- and CpG-methylation-dependent manner.
Zta is a homodimer but its biochemical binding characteristics
to meZREs suggests a sequential, non-palindromic and bipartite
DNA recognition element which confers superior DNA binding
compared to CpG-free ZREs. Our findings indicate that Zta has
evolved to bind to CpG-methylated DNA and transactivate
repressed promoters with meZRE motifs as a rule, which is a novel
means to overcome epigenetic silencing.
Results
A differential, genome-wide screen with recombinant
EBV DNA identifies putative binding sites for Zta
The extensive methylation of genomic EBV DNA during latent
infection has been associated with a repression of viral transcrip-
tion ([16,17] for a recent review). In contrast, our previous work
indicated CpG methylation of viral DNA as a prerequisite for
synthesis of progeny EBV in latently infected cells [3]. Studies with
a mutant EBV revealed that the methylation of viral DNA
necessary for induction of EBV’s lytic cycle is at sites other than
those in the ZREs in the BRLF1 promoter [3]. Therefore, viral
genes downstream of BRLF1 must be responsible for lytic gene
expression from CpG-methylated viral templates.
We wanted to identify all potential sequence elements in EBV that
favor the binding of Zta and used chromatin-immunoprecipitation
coupled to next generation sequencing (ChIP-seq) as the most
promising approach to do so. The 165 kbp genomic DNA of the
EBV B95.8 strain cloned in E.coli [18] and free of methylated CpGs
was used directly or after full CpG methylation in vitro. A chimeric
GFP:BZLF1 protein (Supporting Figure S1A) was transiently
expressed in HEK293 cells and purified with the aid of a GFP-
binding recombinant antibody [19]. Immobilized GFP:BZLF1 was
used to precipitate selectively EBV DNA fragments sheared to a size
of approximately 250 bp as described before [3]. Bound DNAs were
eluted, purified and subjected to library preparation for extensive
next generation sequencing on a GAIIx sequencer (Illumina). We
performed 36-bp single-end reads, which were mapped to the B95.8
EBV reference sequence [20].
In order to represent the data graphically, we normalized the
read depth according to the average of the maximal read depths of
the experiments, where ‘depth’ was defined as the number of times a
single nucleotide residue in EBV DNA was identified. We observed
a high dynamic range of read depth of approximately 1:103. The
background read depth was approximately 10 with interspersed
peaks with a read depth of up to 9000 (Figure 1). The calculated
difference of depths between both kinds of EBV DNAs (Figure 1)
indicated that Zta bound methylated viral DNA preferentially at
multiple sites. In contrast, CpG-methylation of EBV DNA reduced
or abrogated the binding of Zta in only a few positions (Figure 1).
Figures 2 to 5 show exemplary regions of known and novel ZREs
binding sites in higher resolution. Since the discovery of Zta as
sequence-specific DNA binding protein by two groups in 1989
[9,21], a number of ZREs have been described in the EBV genome
(Table S1 in Text S1). For example, our analysis confirmed Zta
binding sites in the divergently oriented promoters of the BHLF1
and BRLF1 genes (Figure 2A) [22], which co-localize with the lytic
origin of DNA replication of EBV, oriLyt [23]. The four ZREs in the
BHLF1 promoter, which reside within a 100bp span, were not
individually resolved but ZRE5, -6, and -7 of oriLyt could be
confirmed with high precision. The two very closely situated ZREs
in the BZLF1 promoter [21,24] localized to a single peak (Figure 2B).
Measurements of binding to unmethylated and CpG-methylated
DNAs did not reveal major differences in the three promoters of
BHLF1, BHRF1 and BZLF1 (blue and red lines, respectively, in
Figure 2A, B) assuming that twofold variations of the peak depth
values resulted from experimental variability.
In the BRLF1 promoter (Figure 2B), two of the three previously
published ZREs could be accurately determined [13,25]. In its
CpG-methylated version, ZRE2 of BRLF1 showed an about
fourfold increase in depth values confirming that this site is bound
by Zta more strongly when methylated [13,26]. ZRE3 of the BRLF1
promoter, which was reported to bind Zta only in its CpG-
methylated version (ibid), was not resolved (Figure 2B) but two
additional and unreported potential ZREs were found upstream of
ZRE2 in this promoter. The peaks of their depth values are set off
by about 60 bp indicating that these potential sites do not colocalize
and differ in their CpG-dependent binding characteristics.
Examples of our immunoprecipitation experiments shown in
Figures 2C and 3 confirmed previously mapped single ZREs in the
promoters of BMRF1 [27,28], BSLF2/BMLF1 [9,21,29], BFRF1
[30], and BALF2 [31,32] but they all contained additional,
previously unidentified potential Zta binding sites, some of which
were bound more strongly when methylated. These immunopre-
cipitations experiments did not confirm the recently published
ZREs in the promoter of BRRF1 [14] (Figure 2B).
The immunoprecipitation experiments also identified numerous
additional Zta binding sites in the promoters of genes, which were
not formerly known to be transactivated by Zta. For example, the
promoters of BSRF1 (Figure 5), BKRF4 (Figure 4A), BBLF4
(Figure 4A), BBLF2/BBLF3 (Figure 4B), and BALF5 (Figure 4C)
were exclusively or preferentially enriched when CpG-methylated.
The genes encode two different viral tegument proteins with
unknown functions, the DNA helicase, the primase-associated
factor, and the DNA polymerase of EBV, respectively. With the
exception of BSRF1 and BKRF4, these genes are directly or
indirectly involved in lytic DNA amplification of virion DNA during
productive infection, BSLF2/BMLF1, BBLF4, BBLF2/BBLF3, and
BALF5 being essential [33,34]. Zta selectively targets a number of
previously unknown methylated ZRE sites, for which we proposed
the term meZRE [3], in the promoters of viral genes essential for
EBV’s lytic cycle. An extreme example is the BBLF4 promoter,
which Zta can only bind when it is CpG-methylated (Figure 4A).
Chromatin immunoprecipitations reveal binding sites for
Zta in vivo
Having found that Zta’s binding to DNA is enhanced in vitro by
methylation of that DNA we set out to test if Zta binds methylated
in the experiments. In vivo ChIP-seq data obtained after immunoprecipitation of chromatin of Raji cells (black) or B95.8 cells (green) with GFP:BZLF1
are plotted. Ten genes, their exon compositions and the location of selected ZREs are shown. (A) The two divergently transcribed genes BHLF1 and
BHRF1, which bracket EBV’s lytic origin of DNA replication are shown. (B) The two genes BZLF1 and BHRF1 and the intervening gene BRRF1 are shown.
(C) The BMRF1 gene is shown, which encodes the viral DNA polymerase accessory protein.
doi:10.1371/journal.ppat.1001114.g002
CpG-Dependent Transcriptional Activation
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Figure 3. Identification of methylation-dependent Zta binding to selected viral promoter elements in vivo and in vitro. Deep
sequencing data obtained from in vitro immunoprecipitation experiments with GFP:BZLF1 as in Figure 1 are plotted on selected genes and their
promoters as indicated. EBV DNA free of CpG-methylation (blue) and after full methylation by the methyltransferase M.SssI (red) were used as probes
CpG-Dependent Transcriptional Activation
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DNA in vivo. We engineered a derivative of the human B-cell line
Raji, which stably expressed a nuclear, chimeric GFP:BZLF1
protein (Supporting Figure S1B,C). Raji cells contain about 50
viral genomes per cell and are strictly latently infected with EBV.
Chromatin immunoprecipitations (ChIPs) with the GFP-binding
recombinant antibody [19] were performed and quantitative real-
time PCR analysis confirmed the highly selective binding of
GFP:BZLF1 to the BBLF4 and BMRF1 promoters as compared to
a reference locus (terminal repeat, TR) and another Raji cell
derivative, which expressed GFP:NLS as a control protein
(Supporting Figure S1; Table S2 in Text S1). ChIP-seq allowed
a direct comparison with our in vitro immunoprecipitations
experiments (Figures 2 to 5). Identical ChIP-seq experiments were
also performed with the B95.8 cell line, which is semipermissive for
EBV’s lytic phase (Figures 2 to 5).
Peak depth values in general coincided with those obtained in
vitro with CpG-methylated EBV DNA as depicted in the promoters
of BMRF1, BSLF2/BMLF1, BBLF4, BBLF2/BBLF3, and BALF5 in
Figures 2C, 3A, 4A, 4B, and 4C, respectively. The Raji EBV
genome is highly CpG-methylated (Supporting Figure S3) and
GFP:BZLF1 revealed a preferential binding to many promoters
mimicking the patterns found with CpG-methylated EBV DNA in
the immunoprecipitation experiments performed in vitro. In
particular, Zta bound to the BBLF4 promoter in vivo exactly
recapitulating the depth profile seen with methylated EBV in vitro
(Figure 4A).
A noticeable exception was the BZLF1 promoter. In vivo, the two
ZREs in the BZLF1 promoter were bound by Zta in B95.8 cells,
but not in Raji cells (Figure 2B) indicating that this promoter is
regulated differently in the two cell lines. With the exception of the
BZLF1 promoter in Raji cells, Zta readily bound many viral lytic
promoters in vivo indicating that that their chromatin configuration
allowed access for Zta’s DNA-binding moiety.
Identification of consensus binding sites of Zta from
ChIP-seq data
The coverage data of mapped reads shown in the panels of
Figures 2 to 5 suggested the discrete localization of ZREs in the
promoters of a number of viral genes. Although genomic regions
enriched with mapped reads could be inferred as approximate
binding sites, the fragment length of approximately 200 bp pose
challenges for determining the exact protein-DNA binding site
within these regions [35]. We therefore applied algorithms
developed to delineate the exact localization of potential binding
sites. Because the data in Figures 2 to 5 indicated that Zta’s bind
differently to unmethylated and CpG-methylated DNAs, we used
the two data sets of our in vitro immunoprecipitation experiments
to investigate whether specific consensus motifs can explain these
differences. We first determined the protein binding sites with
SISSRs (Site Identification from Short Sequence Reads [35]) and
subsequently used these sites to identify statistically overrepresent-
ed consensus motifs within the inferred binding sites with the
MEME (Multiple EM for Motif Elicitation) algorithm [36].
SISSRs with standard settings was applied on in vitro ChIP-seq
data for GFP:BZLF1-precipitated unmethylated and fully CpG-
methylated EBV DNA. The analysis identified 126 and 200
potential peak calls, respectively, which tag the regions of high
sequence read densities. We employed MEME to identify
statistically overrepresented motifs within the selected peak calls
representing inferred binding sites of Zta. MEME identified 101
and 167 sites in ChIP-seq data for GFP:BZLF1-precipitated
unmethylated and fully CpG-methylated EBV DNAs, which
fulfilled the criteria for canonical Zta-binding motifs and are
depicted in Figure 6A and B, respectively, and listed in Supporting
Data S1. The consensus of the motifs obtained with CpG-
methylated EBV DNA contained one obvious (position 6 and 7)
and several less frequent, putative C-G dinucleotide pairs
(Figure 6B). We therefore conducted a second round of MEME
analysis focusing only on those peak-associated sequences with
CpGs. The separate analysis yielded 85 peak calls (56%) with a
second consensus Zta recognition motif, in which a reliable and
prominent C-G pair was evident (Figure 6C, bottom panel) in
marked contrast to the motif shown in Figure 6A and 6C, top
panel, which lacks any C-G dinucleotide.
We analyzed the ChIP-seq data obtained with GFP:BZLF1
immunoprecipitations of Raji and B95.8 cell chromatin with the
QuEST (kernel density estimate of 60, threshold value of 2) [37]
and SISSRs algorithms (default parameters). Subsequent MEME
analysis of a total of 46 identified peak calls yielded a consensus
motif in Raji cells (Figure 6D) reminiscent of the corresponding
motif in Figure 6B. A second round of analysis identified 20
consensus motifs free of CpG pairs (Figure 6E, top panel) and very
similar to the one in Figure 6A. The remaining 26 motifs
contained a consensus motif with CpG dinucleotides (Figure 6E,
bottom panel), which was almost indistinguishable from the one
shown in Figure 6C, bottom panel. Almost identical results were
obtained in our studies with B95.8 cell chromatin (Supporting
Figure S4).
Taken together, in vivo ChIPs with GFP:BZLF1 confirmed our
initial in vitro findings in immunoprecipitation experiments. Both
strategies independently identified two classes of putative Zta
binding sites. T-G-A-G-C/T-A/C-A (Figure 6E, top panel) lacks
any CpG pair and stands for several previously identified Zta
binding sites. The more frequent second class of ZREs is T-G-A-
G-C-G-A-G/T (Figure 6E, bottom panel), contains a consistent
CpG dinucleotide (underlined), is present in the ZRE2 site (T-G-
A-G-C-G-A-T) of the BRLF1 promoter [13,25] but has not been
identified elsewhere.
Surprisingly, our analysis did not identify the previously
proposed sequences of the ZRE3 site (T-C-G-C-G-A-A) in the
BRLF1 promoter [13,15], of the distal ZRE site (T-C-G-C-T-C-C)
in the cellular egr1 gene [38], or of the two ZREs in the BRRF1
promoter (T-G-A-G-C-G-T-G and T-C-G-C-C-C-G-T) [14],
which have been proposed to bind Zta when methylated.
Zta binds preferentially to CpG-methylated viral lytic
promoters
The results in Figures 2 to 5 suggested that Zta binds to a
number of promoters of lytic viral genes when CpG-methylated.
We used electrophoretic mobility shift assays (EMSAs) to re-
evaluate whether purified BZLF1 protein expressed in HEK293
cells can directly bind to viral promoter sequences in a CpG-
methylation-dependent fashion. We examined the promoters of
eleven genes (Table S3 in Text S1), which are all indispensable for
EBV’s lytic phase. Zta bound to the promoters of the BZLF1,
BHLF1, and BHRF1 genes irrespective of their status of CpG-
in the experiments. In vivo ChIP-seq data obtained after immunoprecipitation of chromatin of Raji cells (black) or B95.8 cells (green) with GFP:BZLF1
are plotted. Ten genes, their exon compositions and the location of selected ZREs are shown. (A) The two annotated genes BSLF2 and BMLF1 are
shown, which result in the spliced BMLF2/BSLF1 transcript encoding the viral SM protein also called EB2. (B) The BFRF1 gene is shown. (C) The BALF2
gene is shown, which encodes the major DNA binding protein of EBV.
doi:10.1371/journal.ppat.1001114.g003
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Figure 4. Identification of methylation-dependent Zta binding to selected viral promoter elements in vivo and in vitro. Deep
sequencing data obtained from in vitro immunoprecipitation experiments with GFP:BZLF1 as in Figure 1 are plotted on selected genes and their
promoters as indicated. EBV DNA free of CpG-methylation (blue) and after full methylation by the methyltransferase M.SssI (red) were used as probes
CpG-Dependent Transcriptional Activation
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methylation but CpG methylation of eight promoters increased
Zta’s binding to DNA two- to 20fold (Figure 7). BRLF1 encodes
the immediate early transcription factor Rta, which was previously
found to be regulated in a methylation-dependent fashion [13].
The promoter of the early BSLF2/BMLF1 gene encoding the viral
RNA export factor SM is also preferentially bound by Zta when
methylated. The remaining six genes with this characteristic are
BBLF4, BALF5, BMRF1, BALF2, BSLF1, and BBLF2/3, which are
early viral genes essential for replication of viral DNA and encode
the viral helicase, DNA polymerase, DNA polymerase processivity
factor, DNA binding protein, primase, and primase-associated
factor, respectively.
Zta transactivates methylated promoters of essential viral
genes
We analyzed the promoters of lytic viral genes in luciferase
reporter assays (Figure 8) with the aid of a synthetic reporter
plasmid devoid of CpG dinucleotides to study the effect of CpG-
methylation on the inserted promoter fragments [39]. In these
experiments, the reporter plasmid DNAs were isolated from E.coli
and did not carry methylated CpG dinucleotides. In vitro CpG-
methylation by the de novo methyl transferase M.SssI limited
cytosine methylation to the inserted promoter element. Eleven
different reporter plasmids, either unmethylated or fully methyl-
ated in vitro, were transiently transfected in HEK293 cells and their
luciferase activities were measured. The results shown in Figure 8
revealed that Zta transactivates six viral promoters as a function of
their CpG methylation.
The BRLF1 promoter was only moderately responsive to CpG
methylation (1.7fold) as published previously [13], but CpG
methylation of the promoters of five genes, BALF2, BMRF1,
BBLF4, BALF5 and BSLF2/BMLF1 enhanced luciferase activity
up to 60fold. The BSLF2/BMLF1 promoter was reported to be
responsive to Zta expression [21,29,40] but in our experiments the
unmethylated promoter was repressed by Zta in HEK293 cells,
which might be due to putative negative regulatory regions in the
BSLF2/BMLF1 promoter [41] in line with another earlier report
[42]. Zta did not detectably transactivate the promoters of two
genes, BBLF4 and BALF5 when unmethylated, but CpG
methylation activated them by a factor of 6.7 and 28, respectively.
For unknown reasons, the BSLF1 and BBLF2/3 promoters were
unresponsive to Zta in the luciferase assays although it
preferentially bound to their DNAs when methylated (Figures 4B,
7). Induced expression of Zta in Raji cells led to dramatic
upregulation of all these genes (Table S4 in Text S1) as shown by
quantitative RT-PCR analyses (Supporting Figure S5).
Functional identification of single meZREs
Ten inferred Zta binding sites (Figures 6, 7; Supporting Figure
S4) of five different promoters (BHLF1, BBLF4, BMRF1, BSLF2/
BMLF1, and BALF5) were analyzed as pentamers in a basic
luciferase reporter plasmid free of CpGs [39] in their unmethy-
lated and fully CpG-methylated states. CpG methylation of
meZREs led to a nine to 13-fold activation of luciferase
(Figure 9) indicating that Zta indeed binds to the newly identified
meZREs motifs and activates transcription in a methylation-
in the experiments. In vivo ChIP-seq data obtained after immunoprecipitation of chromatin of Raji cells (black) or B95.8 cells (green) with GFP:BZLF1
are plotted. Ten genes, their exon compositions and the location of selected ZREs are shown. (A) The BBLF4 gene encoding the viral DNA helicase and
the BKRF4 gene are shown. (B) The two open reading frames BBLF2 and BBLF3 are spliced and encode the primase-associated factor BBLF2/3. (C) The
BALF5 and the ECRF4 genes are shown, which encode the viral DNA polymerase and a hypothetical protein, respectively.
doi:10.1371/journal.ppat.1001114.g004
Figure 5. Identification of methylation-dependent Zta binding to the viral BSLF1 and BSLF2/BMLF1 promoter elements in vivo and in
vitro. Deep sequencing data obtained from in vitro immunoprecipitation experiments with GFP:BZLF1 as in Figure 1 are plotted on selected genes
and their promoters as indicated. EBV DNA free of CpG-methylation (blue) and after full methylation by the methyltransferase M.SssI (red) were used
as probes in the experiments. In vivo ChIP-seq data obtained after immunoprecipitation of chromatin of Raji cells (black) or B95.8 cells (green) with
GFP:BZLF1 are plotted. Ten genes, their exon compositions and the location of selected ZREs are shown. The loci of the BSRF1 and BSLF2/BMLF1
genes are shown in conjunction with the BSLF1 gene, which encodes the viral primase.
doi:10.1371/journal.ppat.1001114.g005
CpG-Dependent Transcriptional Activation
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dependent manner in the promoters of BBLF4, BMRF1, BSLF2/
BMLF1, and BALF5. As expected, CpG methylation of ZREs that
do not include CpGs did not stimulate luciferase activity as
exemplified by the BHLF1 promoter (Figure 9). In EMSAs, the
fraction of Zta-bound oligonucleotides with selected, single ZREs
was measured as a function of protein concentration (Supporting
Figure S6). The affinity of Zta transiently expressed in and purified
from HEK293 cells was determined for the different ZREs (Table
S5 in Text S1) fitting the data to the Hill equation [43]. In general,
Zta protein bound to CpG-methylated meZREs with considerably
higher affinities (Kd, app,12 to 16nM) than to conventional
ZREs (Kd, app,40 to 120nM) [44] or unmethylated meZREs
(Kd, app,.200nM) (Table 1). Interestingly, the heterodimeric Fos-
Jun and the homodimeric CREB proteins, members of the AP-1
family, were reported to bind to their cognate recognition motifs
with comparable affinities (10.8nM and 5nM, respectively) and in
the range of meZREs [45,46].
Discussion
Our data identify the structure and function of novel DNA
motifs, which Zta binds with increased affinities or even exclusively
when CpG-methylated. As revealed in our genome-wide search
(Figure 1 and data not shown) more than 20 viral early genes are
potentially regulated by Zta via meZREs. Promoters such as
BBLF4 and BALF5 (Figures 4A, 7) are bound and transactivated
by Zta, only, when their meZREs are CpG-methylated indicating
a newly appreciated level of regulation for the onset of EBV’s lytic
productive phase. Among others, these genes constitute an
essential class of viral proteins indispensable for EBV’s lytic
DNA replication. EBV DNA is unmethylated upon infection, and
this initial state of viral DNA insures an efficient block of EBV’s
lytic phase preventing the onset of virus production and
presumably cellular death of the newly infected cell. The failure
of Zta to bind to unmethylated viral DNA and transactivate
essential viral lytic genes shortly after infection therefore appears
as a prerequisite for stable latent infections of primary B cells
because BZLF1 is expressed immediately after infection [3,47].
Promoters of BBLF4 and BALF5 among other essential lytic genes
become responsive to Zta-mediated transcriptional activation only
later after de novo methylation in latently infected cells [3].
The class of DNA sequences, which Zta binds only when CpG-
methylated, is without precedent and suggests an ingenious bypass
to overcome the restricted state of epigenetic repression of silenced
chromatin with CpG-methylated DNA. Remarkably, Zta can gain
access to and bind to these meZREs in vivo despite the strictly
repressed and heavily CpG-methylated chromatin of EBV DNA
(Supporting Figures S3, S5; Figures 2 to 5; data not shown).
GFP:BZLF1 encompasses Zta’s DNA binding and dimerization
domains, only, suggesting that Zta’s binding to DNA is
independent of active chromatin remodeling and/or histone
modifications in vivo (Figures 2 to 5; Supporting Figure S2). It is
likely that the transactivation domain of full length Zta induces
these modifications to facilitate transcription because Zta interacts
with CBP [48,49]. Promoters with meZREs are silent in Raji cells
but readily accessible to Zta’s binding and poised for expression
(Supporting Figure S5), a situation reminiscent of the bivalent
marks in chromatin of embryonic stem cells during developmental
differentiation [50–52].
Understanding how Zta binds meZREs with increased affinities
summarized in Table 1 is fundamentally important. Zta is a member
of the AP-1 transcription factor family [9], which in marked contrast
to many AP-1 family members binds non-palindromic recognition
elements as a homodimer (similar to homodimeric Jun-Jun). Zta can
also bind to the classical, symmetric AP-1 consensus T-G-A-C/G-T-
C-A (Table 1). The crystal structure of this complex was solved [53],
which, however, does not resolve the riddle of how Zta binds with
similar affinities to asymmetric recognition motifs of conventional
ZREs and to meZREs with even higher affinities when methylated
[15]. In fact, heterodimeric Fos-Jun and ATF2-Jun complexes
exhibit orientation-dependent preferences in binding to AP-1 sites
[54] suggesting non-identical recognition of the two half sites of the
Figure 6. Motif discovery of Zta bound to unmethylated, CpG-
methylated EBV DNA or Raji cell chromatin. ChIP-seq data and
deep sequencing data after in vitro immunoprecipitation assays with
GFP:BZLF1 were analyzed with the SISSRs (default parameters) or QuEST
algorithms (kernel density estimate of 60, threshold value of 2) for
putative stretches of DNA to which Zta binds. The outputs of SISSRs or
QuEST were used as training sets for MEME, which identifies gapless,
local, multiple sequence motifs [59]. (A) A total of 101 motifs were
identified in in vitro immunoprecipitation experiments followed deep
sequencing with E.coli-derived EBV DNA free of CpG methylation. (B) A
total of 167 motifs were identified in in vitro immunoprecipitation
experiments followed deep sequencing with fully CpG-methylated
E.coli-derived EBV DNA. (C) The identified motifs in (B) were selected at
the level of the SISSRs training set data and grouped into ZRE motifs
with (bottom panel) and without (top panel) CpG dinucleotides
followed by MEME analysis. (D) A total of 46 motifs were identified in
ChIP-seq data after chromatin immunoprecipitations from Raji cells
stably transfected with an expression plasmid encoding GFP:BZLF1
(Supporting Figure S1). (E) The identified motifs in (D) were selected at
the level of the QuEST training set data and grouped into ZRE motifs
encompassing no (top panel) or one or more (bottom panel) CpG
dinucleotides. Subsequent MEME analysis identified two classes of ZREs.
doi:10.1371/journal.ppat.1001114.g006
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AP-1 recognition sequence by Fos, ATF2 and Jun. Jun binds
preferentially to the consensus at asymmetric recognition sequences
whereas Fos binds to the non-consensus half site affecting
transactivation and cooperativity with other transcription factors
such as NF-AT [55]. How Zta binds to non-palindromic sequences
remains to be addressed experimentally but the structural similarities
of homodimeric Zta and heterodimeric Fos-Jun when bound to
DNA [53,56] support a model in which certain members of the AP-1
transcription factor family also ‘read’ DNA sequences in a
methylation-dependent manner. In this model Zta would be the
founding example in a mechanism that directly promotes transcrip-
tional regulation of repressed cellular chromatin.
Materials and Methods
Cells
HEK293, B95.8 and Raji cells have been described and were
maintained in RPMI medium with 10% fetal calf serum (FCS),
1% penicillin-streptomycin and 1% sodium-pyruvate at 37uC and
5% CO2.
Plasmids
The wild-type maxi-EBV plasmid (p2089) encompassing the
complete genome of the EBV prototype B95.8 strain and the
BZLF1 expression plasmid have been described. The GFP:BZLF1
expression plasmid p3927 was described recently [3]. The
GFP:NLS expression plasmid p4247 served as a control and
contains the nuclear localization signal from SV40 T-antigen
(amino acids PKKKRKVG) cloned in phase with the GFP gene
expressed from the CMV promoter in pEGFP-C1 (Clontech). The
BZLF1:Strep/FLAG expression plasmid (p3928) contains amino
acids 149–245 of BZLF1 cloned in phase with a tandem StrepII/
FLAG-tag [57]. Luciferase plasmids were constructed by PCR
amplifying the promoter fragments of interest (Table S3 in Text
S1) from B95.8 genomic EBV-DNA and inserted upstream of the
CpG-basic vector described [39].
Stable transfection and establishment of cell lines
5 mg DNA of either p3927 (GFP:BZLF1) or p4247 (GFP:NLS)
DNA was transfected into 56106 cells by electroporation in 250 ml
Optimem (Invitrogen) at 230 V and 975 mF using a Biorad
electroporation apparatus in 4mm cuvettes. Immediately after
electroporation, cells were resuspended in 400ml FCS and 10 ml
growth medium was added. Cells were incubated in tissue culture
flask at 37uC and 5% CO2 for two days. Afterwards cells were
plated into 96-well plates in 200ml growth medium supplemented
with G418 (1.5 mg/ml for Raji cells and 1.0 mg/ml for B95.8
cells). Within the next 4–5 weeks, G418 resistant cells grew out.
When an appropriate cell density was reached, cells were
expanded successively into 48 and 24 well plates. Cells were
maintained in culture under G418 selection.
DNA transfection
DNA transfections into HEK293 cells were performed using
polyethylenimine (PEI) (Sigma-Aldrich). Transfection mixtures
and transfection reactions were prepared as recently described [3].
For protein extracts 56106 cells per 15mm dish were seeded the
day prior to transfection. Each plate was transfected with 15mg
BZLF1:Strep/FLAG (p3928). For reporter assays 3.56105
HEK293 cells were seeded into six-well cluster plates the day
before transfection. Each well was co-transfected with 1mg of
reporter plasmid together with 0.5mg transactivator (p509) and
0.05mg renilla plasmid DNA as an internal control for data
normalization.
In vitro immunoprecipitation assays with GFP:BZLF1
The DNA binding and dimerization domain of BZLF1 (amino
acid residue #149 to #245) was cloned in phase downstream of
the coding region of eGFP in pEGFP-C1 (Clontech) to generate
the expression plasmid p3927.1. This plasmid was transiently
transfected into HEK293 cells, which expressed the GFP:BZLF1
chimera at high levels as a nuclear protein. The GFP:BZLF1
protein was purified from the cells and in vitro immunoprecipita-
tion assays with E.coli-derived genomic EBV DNA were
performed as described in detail [3].
Native chromatin immunoprecipitations (ChIP)
56107 Raji cells stably transfected with GFP:BZLF1 were
collected and washed 3 times with ice cold PBS. Cells were
resuspended in a hypotonic buffer (10mM Hepes, 10mM KCl,
340mM sucrose, 1.5mM MgCl2, pH 7.9) and incubated on ice for
15min. Nuclei were prepared by adding Triton-X 100 (Sigma) to
the swollen cells at a final concentration of 0.1%. Nuclei were
collected by centrifugation and lysed with RIPA buffer (50mM
Tris, 150mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, ph 8.0)
for 15 minutes on ice and chromatin was sheared by sonication to
an average size of 250–350 bp. DNA-bound GFP:BZLF1 was
immunoselected and immobilized with a GFP-Nanotrap reagent
at 4uC over night. The immunocomplex was washed with low salt
buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-
HCl, pH 8.1, 150mM NaCl), high salt buffer (0.1% SDS, 1%
Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 500mM
NaCl) and TE-buffer (10mM Tris, 0.5mM EDTA, pH 8.0). The
beads were resuspended in elution buffer (10mM Tris, 0.5 mM
EDTA, 2% SDS, pH 8.0 containing 20mg proteinase K) and
incubated at 65uC for 2h. Protein-free DNA was phenol extracted,
precipitated and analyzed by real-time PCR or ChIP-seq.
Electromobility shift assays (EMSA)
EMSAs were performed with purified protein from HEK293
cells, transiently transfected with BZLF1:Strep/FLAG (p3928).
Two days post transfection, cells from eight 15mm plates were
pooled and lysed in 10ml RIPA-buffer (50mM Tris, 150mM
NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, pH 8.0). Cell lysates
were sonicated and BZLF1:Strep/FLAG was column affinity
purified with Strep-Tactin sepharose as described by the
manufacturer (iba-biotagnology). BZLF1:Strep/Flag was eluted
in 500ml Strepelution buffer. For each EMSA reaction 1 ml of a
1:10 dilution of purified protein was incubated with 5000cpm of
radioactive labeled probe in the presence of 20mM Hepes, 75mM
Figure 7. Zta binds preferentially to CpG-methylated promoters. In EMSAs, Zta bound preferentially to the CpG methylated promoters of
BRLF1, BALF2, BSLF2/BMLF1, BALF5 and BMRF1 and BSLF1 but it bound only the CpG-methylated promoters of BBLF4 and BBLF2/3. CpG methylation
did not influence Zta binding to the promoters of BZLF1, BHLF1, and BHRF1. EMSAs were performed with affinity-purified Strep/FLAG-tagged BZLF1
fusion protein transiently expressed in HEK293 cells. Eleven PCR fragments encompassing EBV promoters with BZLF1 binding sites identified in
Figures 2 to 5 served as radioactive probes. PCR fragments (Table S3 in Text S1) were used either unmethylated or fully CpG-methylated in vitro with
M.SssI. Supershifts with a FLAG-antibody confirmed the identity of the protein-DNA complexes. The signals were scanned and the percent ratios of
bound DNAs versus total input DNAs are shown for each sample.
doi:10.1371/journal.ppat.1001114.g007
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NaCl, 10% glycerin, 2mg polydIdC (Roche), 2mM MgCL2 100ng
calf thymus DNA and 0.1mg/ml BSA. EMSA probes were created
by PCR amplification to generate promoter specific large probes
(Table S3 in Text S1). Oligonucleotides containing single ZREs
were provided by Sigma-Aldrich or Metabion in a CpG-
methylated or an unmethylated form (Table S5 in Text S1).
Probes were 32P end-labeled with T4 polynucleotide kinase
(Promega) in accordance with the manufacturer’s instructions.
For Kd-value calculation annealed double-stranded oligonucleo-
tides (250pM) were incubated with twofold serial dilutions of
purified BZLF1:Step/Flag protein for 30 minutes. Unbound DNA
was separated from Protein-DNA complexes by polyacrylamide
gel electrophoresis (12% (w/v) 29:1 acrylamide/bisacrylamide,
0.56TBE). Gels were scanned using a phosphoimager (FLA 5100,
Fuji) and the ratio of the free and bound DNA was calculated.
These data were fit to the Hill equation with one site specific
binding using the Prism 5 (graphpad.com) software to determine
the dissociation constant.
In vitro methylation
Luciferase reporter constructs and PCR fragments (EMSAs)
were methylated in vitro with the de novo methyltransferase M.SssI
and S-adenosyl methionine (SAM) as the methyl donor. 15mg
plasmid DNA or 5mg PCR-product were incubated with 40U
M.SssI (New England Biolabs) and 1ml SAM (32mM stock
concentration) in 150ml H2O buffered with NEB buffer 2 at
37uC over night. The next day the reaction was again supplied
with 1ml SAM and further incubated for 2 hours. Complete CpG-
methylation of plasmids and PCR fragments was confirmed by
digestion with the methylation-sensitive restriction enzyme HpaII
(New England Biolabs).
Luciferase reporter assays
48 hours post transfection the HEK293 cells were analyzed with
the Dual-Luciferase Reporter Assay System (Promega). Luciferase
activity was measured in a 96-well microplate luminometer (Orion
II, Berthold).
Library construction
Sequence libraries were constructed with paired-end DNA
sample preparation kits (Illumina) according to the manufacture’s
recommendations with minor modifications. Briefly, 500ng of
double-stranded DNA fragments were converted to blunt ends
using T4 DNA polymerase and Klenow polymerase. Subsequently
a single adenine base was added to the DNA using Klenow exo-
(39 to 59 exo minus). Next, paired end DNA adaptors with a single
thymidine base overhang at the 39 end were ligated to the above
products. The adaptor-modified DNA fragments were then
separated on a 2% low melting agarose gel (Biozym), a 300+/
225 bp DNA band was excised from the gel and purified (Qiagen
Gel Extraction Kit). 12 cycles of PCR enrichment with paired end
PCR primers 1.0 and 2.0 (Illumina) were performed. The purified
(Qiagen MinElute PCR purification kit) libraries were quantified
using an Agilent bioanalyzer. Library hybridization to the flow
cells and cluster generation was performed on an Illumina cluster
station following the manufactures protocols (Illumina paired-end
cluster generation kit GAII v1, 36-cycle sequencing kit v1).
Read mapping
Sequencing was performed on an Illumina Genome Analyzer
IIx. In vitro immunoprecipitations with unmethylated and fully
CpG-methylated EBV DNAs were converted into the libraries
‘44466_unmethylated’ and ‘44467_methylated’, respectively. We
generated 6.13 million and 3.78 million 36-bp single-end reads for
libraries ‘44466_unmethylated’ and ‘44467_methylated’, respec-
tively. DNA obtained with ChIP of Raji cell chromatin was
converted into the library ‘46312_Raji_BZLF1’, which was
analyzed with 6.13 million 36-bp paired-end reads.
Read mapping to the reference sequence and subsequent
assembly was performed using the re-sequencing software MAQ
(v0.7.1; [58]). We used a combination of the EBV (recombinant
EBV strain 2089) [18] and the bovine genome (build bosTau4) as
reference sequences for the two libraries ‘44466_unmethylated’
and ‘44467_methylated’. (Calf thymus DNA was used as an
unspecific competitor in the in vitro immunoprecipitation assays
with GFP:BZLF1.) The reference sequence for the in vivo sample
was composed of the recombinant 2089 EBV genome and the
human reference sequence (build hg18). Approximately 83–87%
of the reads mapped to reference sequences. Duplicated reads of
the library ‘46312_Raji_BZLF1’ (0.55%), as defined by identical
outer coordinates of mate-pair reads, were removed.
Transcription factor binding site detection
Genomic regions with a read depth above the background level
are considered as transcription factor binding sites. We used two
different programs, SISSRs [35] and QuEST [37] to identify these
regions. Transcription factor binding sites are typically shorter
than the sequenced DNA fragments. Both programs employ
methods to infer the position of the binding sites within the reads
from the densities of the forward and reverse reads.
The SISSRs algorithm uses the read direction (sense or antisense
strand), density of reads and the average DNA fragment length to
identify potential binding sites. The genome is therefore scanned in a
sliding window approach using a window size of 20 bp (default) with
consecutive windows overlapping 10 bp. For each window the net tag
count, defined as the number of reads on the sense strand subtracted by
the number of reads on the antisense strand, is computed. The
algorithm then identifies transitions from positive to negative net tag
count and records the transition points as potential binding site, which
needs to satisfy further criteria to be considered a true binding site.
These further criteria include threshold values for the individual
positive and negative net tag counts as well as a threshold for the
combined count of positive and negative tags. This combined count,
referred to as number of directed reads supporting the site, is then also
interpreted as score to rank binding sites.
Binding sites in this study were inferred using the default
SISSRs parameters.
The second algorithm employed for peak calling is QuEST [37].
Similar to SISSRs, QuEST uses read counts from forward and
reverse genomic strands as well as the average fragment length as
information, yet they differ in several key points. QuEST’s statistical
framework is based on the kernel density approach to aggregate the
signal originating from densely clustered reads at potential binding
sites. As only the first 36 base pairs of each DNA fragment get
sequenced, forward and reverse strand reads accumulate on
Figure 8. Zta transactivates CpG-methylated promoters with superior efficiency. Promoters of eleven different genes (Table S3 in Text S1)
were inserted into a synthetic luciferase reporter plasmid free of CpG-dinucleotides [39]. Reporter plasmids were either used after isolation from E.coli
and thus free of methylated CpG dinucleotides (unmethylated, white) or after complete in vitro CpG-methylation (black) and co-transfected with a
BZLF1 expression plasmid or with a negative control DNA as indicated (none). After data normalization to a luciferase control plasmid free of
promoter elements, the x-fold differences in the different data sets were calculated as shown.
doi:10.1371/journal.ppat.1001114.g008
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Figure 9. Functional identification of single ZREs and meZREs. Pentamers of ten single ZREs present in the promoters of BHLF1, BBLF4,
BMRF1, BSLF2/BMLF1, and BALF5 were introduced into a basic luciferase reporter plasmid with a minimal EF1a promoter and free of CpGs [39].
Unmethylated and fully CpG methylated reporter constructs were analyzed in the presence or absence of a co-transfected BZLF1 expression plasmid.
doi:10.1371/journal.ppat.1001114.g009
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opposite sides, leading to an under-representation of reads at the
actual binding site. To cope with this, QuEST constructs two
density profiles, one for forward and one for reverse reads, then
combines both profiles in a procedure termed ‘‘peak-shift’’. The
actual distance of the peak-shift is defined as half the distance
between forward and reverse profile andmay vary between different
experiments depending on the DNA fragment length distribution.
After determining the experiment-specific peak-shift, both density
profiles are shifted accordingly and summed to produce a combined
density profile, which is employed in all further analysis. Actual
binding sites are determined by scanning the combined density
profiles for local maxima with sufficient enrichment when compared
to the background model or control data. The output of QuEST is a
list of all potential binding sites with genomic coordinates, ranked
according to their kernel density estimation-derived scores.
In order to identify consensus motifs within the discovered
binding sites, the sequences around the binding sites were
extracted and used as input for the motif finding algorithm
MEME [36]. Default parameters were used for MEME.
Supporting Information
Text S1 Supporting Tables S1 to S5, figure legends for
Supporting Figures S1 to S6.
Found at: doi:10.1371/journal.ppat.1001114.s001 (0.13 MB
DOC)
Figure S1 Analysis of GFP fusion proteins stably expressed in
Raji cell lines.
Found at: doi:10.1371/journal.ppat.1001114.s002 (6.84 MB PDF)
Figure S2 GFP:BZLF1 binds sequence-specifically to selected
EBV promoters in vivo.
Found at: doi:10.1371/journal.ppat.1001114.s003 (0.02 MB PDF)
Figure S3 MeDIP (Methylated DNA Immunoprecipitation)
analysis indicates a high degree of CpG methylation of genomic
EBV DNA in Raji cells.
Found at: doi:10.1371/journal.ppat.1001114.s004 (0.19 MB PDF)
Figure S4 Motif discovery of Zta binding to B95.8 DNA in
ChIP-seq data. ChIP-seq data were selected via the SISSRs
algorithms (default parameters) [3] and the output was used as the
training set for MEME (Multiple EM for Motif Elicitation), which
identifies gapless, local, multiple sequence motifs [4]. (A) A total of
39 motifs were identified shown as a consensus logo motif in the
unselected SISSRs data training set. (B) The identified motifs in
(A) were selected at the level of the SISSRs training set data and
grouped into ZRE motifs with (bottom panel) and without (top
panel) CpG dinucleotides followed by MEME analysis.
Found at: doi:10.1371/journal.ppat.1001114.s005 (1.18 MB PDF)
Figure S5 BZLF1 induces expression of genes essential for viral
replication in vivo. A conditional expression plasmid [5] encoding a
tetracycline-regulated BZLF1 allele (p3862) was stably introduced into
Raji cells. Total cellular RNAs were isolated before (2dox) and twelve
hours after addition of doxycyclin (+dox). After reverse transcription
relative levels of selected viral transcripts were assessed by quantitative
real-time PCRs, which were normalized to the constitutive transcripts
level of the housekeeping cytochrome c (cyt) gene.
Found at: doi:10.1371/journal.ppat.1001114.s006 (0.03 MB PDF)
Figure S6 EMSA quantification of the fraction of selected Zta-
bound unmethylated und methylated ZRE oligonucleotides and
determination of Kd app. In EMSAs, the fraction of Zta-bound
oligonucleotides with selected, single ZREs was measured as a
function of protein concentration and the Kd values of Zta and
different unmethylated and CpG-methylated ZREs were deter-
mined as described [6]. EMSAs of typical experiments are shown
as examples.
Found at: doi:10.1371/journal.ppat.1001114.s007 (1.55 MB TIF)
Supporting Data S1 Training sets and MEME output files.
Found at: doi:10.1371/journal.ppat.1001114.s008 (0.44 MB
DOC)
Acknowledgments
We thank Bill Sugden for continuous discussions, suggestions and critical
reading of the manuscript, Dierk Niessing for valuable advice and Dagmar
Pich for her important experimental contributions.
Author Contributions
Conceived and designed the experiments: MB MK WH. Performed the
experiments: MB MK AS CG ABP. Analyzed the data: MB AS SE TMS
WH. Contributed reagents/materials/analysis tools: UR SE. Wrote the
paper: WH.
References
1. Maatouk DM, Kellam LD, Mann MR, Lei H, Li E, et al. (2006) DNA
methylation is a primary mechanism for silencing postmigratory primordial
germ cell genes in both germ cell and somatic cell lineages. Development 133:
3411–3418.
Table 1. Binding affinities of Zta to selected unmethylated and CpG-methylated ZREs.
ZRE EBV coordinates*
Binding motif (CpG
underlined)
Kd app [nM] methylated
mean ± SD
Kd app [nM] unmethylated
mean ± SD
BBLF4 ZRE A 114487:114511 TGTGCGAG 16.362.6 219641
BBLF4 ZRE B 114609:114633 TGAGCGTT 18.064.2 4846244
BMRF1 ZRE A 79611:79635 ATGTGCGAG 20.2612.5 3286166
BRLF1 ZRE2 106363:106387 TGAGCGA 12.768.2 113611.9
BRLF1 ZRE3 106423:106447 TTCGCGA 135645 11896227
oriLyt ZRE5 53462:53486 TTGCACA nd 37.764.3
BMLF1 ZRE AP-1 84420:84444 TGACTCA nd 40.8623.0
BHLF1 ZRE2 52844:52867 TTGCTCA nd 91.6638.5
*EBV B95.8 strain; nd: not done.
doi:10.1371/journal.ppat.1001114.t001
CpG-Dependent Transcriptional Activation
PLoS Pathogens | www.plospathogens.org 15 September 2010 | Volume 6 | Issue 9 | e1001114
2. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, et al. (2008) Lineage-
specific polycomb targets and de novo DNA methylation define restriction and
potential of neuronal progenitors. Mol Cell 30: 755–766.
3. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W (2010) AP-1
homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on
the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107:
850–855.
4. Kieff E, Rickinson AB (2007) Epstein-Barr virus and its replication. In:
Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B,
Straus SE, eds. Fields Virology. Philadelphia: Lippincott - Williams & Wilkins.
pp 2603–2654.
5. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev
Cancer 4: 757–768.
6. Takada K, Shimizu N, Sakuma S, Ono Y (1986) Transactivation of the latent
Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.
J Virol 57: 1016–1022.
7. Countryman J, Jenson H, Seibl R, Wolf H, Miller G (1987) Polymorphic
proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses
disrupt latency. J Virol 61: 3672–3679.
8. Sinclair AJ (2003) bZIP proteins of human gammaherpesviruses. J Gen Virol 84:
1941–1949.
9. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T (1989) Epstein-Barr virus
BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to
c-fos. EMBO J 8: 127–132.
10. Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, et al. (1986)
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are
required to activate transcription from an EBV early promoter. Embo J 5:
3243–3249.
11. Schepers A, Pich D, Hammerschmidt W (1993) A transcription factor with
homology to the AP-1 family links RNA transcription and DNA replication in
the lytic cycle of Epstein-Barr virus. Embo J 12: 3921–3929.
12. Feederle R, Kost M, Baumann M, Janz A, Drouet E, et al. (2000) The Epstein-
Barr virus lytic program is controlled by the co-operative functions of two
transactivators. EMBO J 19: 3080–3089.
13. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2004) The EBV lytic
switch protein, Z, preferentially binds to and activates the methylated viral
genome. Nat Genet 36: 1099–1104.
14. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, et al. (2009)
Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral
promoters. PLoS Pathog 5: e1000356.
15. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ (2008) Methylated
DNA recognition during the reversal of epigenetic silencing is regulated by
cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS
Pathog 4: e1000005.
16. Schaefer BC, Strominger JL, Speck SH (1997) Host-cell-determined methylation
of specific Epstein-Barr virus promoters regulates the choice between distinct
viral latency programs. Mol Cell Biol 17: 364–377.
17. Minarovits J (2006) Epigenotypes of latent herpesvirus genomes. Curr Top
Microbiol Immunol 310: 61–80.
18. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W (1998)
Propagation and recovery of intact, infectious Epstein-Barr virus from
prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245–8250.
19. Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, et al.
(2008) A versatile nanotrap for biochemical and functional studies with
fluorescent fusion proteins. Mol Cell Proteomics 7: 282–289.
20. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, et al. (1984) DNA
sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:
207–211.
21. Urier G, Buisson M, Chambard P, Sergeant A (1989) The Epstein-Barr virus
early protein EB1 activates transcription from different responsive elements
including AP-1 binding sites. EMBO J 8: 1447–1453.
22. Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD (1990)
The zta transactivator involved in induction of lytic cycle gene expression in
Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in
target promoter and enhancer regions. J Virol 64: 1143–1155.
23. Hammerschmidt W, Sugden B (1988) Identification and characterization of
oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55: 427–433.
24. Flemington E, Speck SH (1990) Autoregulation of Epstein-Barr virus putative
lytic switch gene BZLF1. J Virol 64: 1227–1232.
25. Packham G, Economou A, Rooney CM, Rowe DT, Farrell PJ (1990) Structure
and function of the Epstein-Barr virus BZLF1 protein. J Virol 64: 2110–2116.
26. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2005) BZLF1 activation
of the methylated form of the BRLF1 immediate-early promoter is regulated by
BZLF1 residue 186. J Virol 79: 7338–7348.
27. Kenney SC, Holley-Guthrie E, Quinlivan EB, Gutsch D, Zhang Q, et al. (1992)
The cellular oncogene c-myb can interact synergistically with the Epstein-Barr
virus BZLF1 transactivator in lymphoid cells. Mol Cell Biol 12: 136–146.
28. Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL,
et al. (1993) Direct BRLF1 binding is required for cooperative BZLF1/BRLF1
activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res
21: 1999–2007.
29. Rooney CM, Rowe DT, Ragot T, Farrell PJ (1989) The spliced BZLF1 gene of
Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the
virus productive cycle. J Virol 63: 3109–3116.
30. Granato M, Farina A, Gonnella R, Santarelli R, Frati L, et al. (2006) Regulation
of the expression of the Epstein-Barr virus early gene BFRF1. Virology 347:
109–116.
31. Hung CH, Liu ST (1999) Characterization of the Epstein-Barr virus BALF2
promoter. J Gen Virol 80: 2747–2750.
32. Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, et al. (2009) Epstein-
Barr Virus Polymerase Processivity Factor Enhances BALF2 Promoter
Transcription as a Coactivator for the BZLF1 Immediate-Early Protein. J Biol
Chem 284: 21557–21568.
33. Fixman ED, Hayward GS, Hayward SD (1992) trans-acting requirements for
replication of Epstein-Barr virus ori-Lyt. J Virol 66: 5030–5039.
34. Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, et al. (2002) Epstein-Barr
virus mRNA export factor EB2 is essential for production of infectious virus.
J Virol 76: 9635–9644.
35. Jothi R, Cuddapah S, Barski A, Cui K, Zhao K (2008) Genome-wide
identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic
Acids Res 36: 5221–5231.
36. Bailey TL, Williams N, Misleh C, Li WW (2006) MEME: discovering and
analyzing DNA and protein sequence motifs. Nucleic Acids Res 34: W369–73.
37. Valouev A, Johnson DS, Sundquist A, Medina C, Anton E, et al. (2008)
Genome-wide analysis of transcription factor binding sites based on ChIP-Seq
data. Nat Methods 5: 829–834.
38. Heather J, Flower K, Isaac S, Sinclair AJ (2009) The Epstein-Barr virus lytic
cycle activator Zta interacts with methylated ZRE in the promoter of host target
gene egr1. J Gen Virol 90: 1450–1454.
39. Klug M, Rehli M (2006) Functional analysis of promoter CpG methylation using
a CpG-free luciferase reporter vector. Epigenetics 1: 127–130.
40. Buisson M, Manet E, Trescol BM, Gruffat H, Durand B (1989) The Epstein-
Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed
under the control of EBV transcription factors EB1 and R. J Virol 63:
5276–5284.
41. Liu Q, Summers WC (1992) Identification of the 12-O-tetradecanoylphorbol-
13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus. J Biol
Chem 267: 12049–12054.
42. Kenney S, Holley-Guthrie E, Mar EC, Smith M (1989) The Epstein-Barr virus
BMLF1 promoter contains an enhancer element that is responsive to the BZLF1
and BRLF1 transactivators. J Virol 63: 3878–3883.
43. Ryder SP, Recht MI, Williamson JR (2008) Quantitative analysis of protein-
RNA interactions by gel mobility shift. Methods Mol Biol 488: 99–115.
44. Lehman AM, Ellwood KB, Middleton BE, Carey M (1998) Compensatory
energetic relationships between upstream activators and the RNA polymerase II
general transcription machinery. J Biol Chem 273: 932–939.
45. Chytil M, Peterson BR, Erlanson DA, Verdine GL (1998) The orientation of the
AP-1 heterodimer on DNA strongly affects transcriptional potency. Proc Natl
Acad Sci U S A 95: 14076–14081.
46. Williams JS, Andrisani OM (1995) The hepatitis B virus X protein targets the
basic region-leucine zipper domain of CREB. Proc Natl Acad Sci U S A 92:
3819–3823.
47. Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, et al. (2007) Epstein-Barr
virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an
immediate-early gene after primary infection of B lymphocytes. J Virol 81:
1037–1042.
48. Adamson AL, Kenney S (1999) The Epstein-Barr virus BZLF1 protein interacts
physically and functionally with the histone acetylase CREB-binding protein.
J Virol 73: 6551–6558.
49. Zerby D, Chen CJ, Poon E, Lee D, Shiekhattar R, et al. (1999) The amino-
terminal C/H1 domain of CREB binding protein mediates zta transcriptional
activation of latent Epstein-Barr virus. Mol Cell Biol 19: 1617–1626.
50. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA (2007) A
chromatin landmark and transcription initiation at most promoters in human
cells. Cell 130: 77–88.
51. Mellor J, Dudek P, Clynes D (2008) A glimpse into the epigenetic landscape of
gene regulation. Curr Opin Genet Dev 18: 116–122.
52. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-
wide maps of chromatin state in pluripotent and lineage-committed cells. Nature
448: 553–560.
53. Petosa C, Morand P, Baudin F, Moulin M, Artero JB, et al. (2006) Structural
basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell
21: 565–572.
54. Leonard DA, Kerppola TK (1998) DNA bending determines Fos-Jun
heterodimer orientation. Nat Struct Biol 5: 877–881.
55. Ramirez-Carrozzi V, Kerppola T (2003) Asymmetric recognition of non-
consensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional
cooperativity with NFAT1. Mol Cell Biol 23: 1737–1749.
56. Glover JN, Harrison SC (1995) Crystal structure of the heterodimeric bZIP
transcription factor c-Fos-c-Jun bound to DNA. Nature 373: 257–261.
57. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M (2007) A novel
tandem affinity purification strategy for the efficient isolation and characterisa-
tion of native protein complexes. Proteomics 7: 4228–4234.
58. Li H, Ruan J, Durbin R (2008) Mapping short DNA sequencing reads and
calling variants using mapping quality scores. Genome Res 18: 1851–1858.
59. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. (2009) MEME
SUITE: tools for motif discovery and searching. Nucleic Acids Res 37: W202–8.
CpG-Dependent Transcriptional Activation
PLoS Pathogens | www.plospathogens.org 16 September 2010 | Volume 6 | Issue 9 | e1001114
